Company / Operating Margin
Alaunos Therapeutics, Inc. Operating Margin History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-48120.0%
FY2025
5-year range
-685340.0% / -1201.4%
FY2021-FY2025
Trend
+93.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 8 years, ranging from -685340.0% in FY2024 to -336.4% in FY2019.
Based on SEC 10-K filings.
-48120.0% in FY2025 with a 5-year CAGR of -11198.1%.
Declined from -1201.4% to -48120.0% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -28635.3pp
- 5-Year Change
- -11198.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 93.0% year-over-year.
- Peak operating margin was recorded in FY2019.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -48120.0% | +93.0% |
| FY2024 | -685340.0% | -56945.1% |
| FY2023 | -1201.4% | +93.8% |
| FY2022 | -19484.7% | - |
| FY2021 | - | - |
| FY2020 | -36921.9% | -10874.6% |
| FY2019 | -336.4% | +67.6% |
| FY2018 | -1039.7% | - |
| FY2013 | - | - |
| FY2012 | -3680.1% | -102.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026